Concepts (102)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mitosis | 7 | 2007 | 22 | 1.580 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 4 | 2007 | 38 | 0.740 |
Why?
|
| G2 Phase | 5 | 2007 | 14 | 0.650 |
Why?
|
| Cell Cycle | 2 | 2005 | 75 | 0.520 |
Why?
|
| Anaphase | 3 | 2007 | 3 | 0.420 |
Why?
|
| DNA Damage | 3 | 2005 | 92 | 0.380 |
Why?
|
| Microscopy, Video | 2 | 2004 | 7 | 0.350 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2007 | 70 | 0.340 |
Why?
|
| Microtubules | 2 | 2009 | 18 | 0.340 |
Why?
|
| Microscopy, Fluorescence | 2 | 2004 | 82 | 0.330 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2004 | 19 | 0.290 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2004 | 38 | 0.280 |
Why?
|
| Kidney Transplantation | 2 | 2019 | 320 | 0.280 |
Why?
|
| Biosensing Techniques | 1 | 2004 | 17 | 0.270 |
Why?
|
| Cell Nucleus | 1 | 2004 | 113 | 0.260 |
Why?
|
| Metaphase | 1 | 2002 | 2 | 0.260 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2004 | 115 | 0.250 |
Why?
|
| Nocodazole | 1 | 2002 | 3 | 0.250 |
Why?
|
| Hela Cells | 5 | 2009 | 77 | 0.230 |
Why?
|
| Neoplasm Proteins | 1 | 2002 | 143 | 0.220 |
Why?
|
| Complement C4b | 1 | 2017 | 2 | 0.180 |
Why?
|
| Proteinuria | 1 | 2017 | 63 | 0.180 |
Why?
|
| Kidney Glomerulus | 1 | 2017 | 35 | 0.170 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2019 | 115 | 0.170 |
Why?
|
| Kidney Neoplasms | 1 | 2019 | 199 | 0.160 |
Why?
|
| Enzyme Activation | 3 | 2006 | 133 | 0.160 |
Why?
|
| Kidney Diseases | 1 | 2017 | 240 | 0.140 |
Why?
|
| Cell Cycle Proteins | 2 | 2007 | 58 | 0.140 |
Why?
|
| Piperazines | 2 | 2004 | 54 | 0.130 |
Why?
|
| Peptide Fragments | 1 | 2017 | 514 | 0.130 |
Why?
|
| Humans | 10 | 2019 | 29158 | 0.110 |
Why?
|
| Benzylidene Compounds | 1 | 2009 | 6 | 0.100 |
Why?
|
| Pyridines | 1 | 2009 | 89 | 0.090 |
Why?
|
| Retinoblastoma Protein | 1 | 2007 | 9 | 0.090 |
Why?
|
| ras Proteins | 1 | 2007 | 11 | 0.090 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2007 | 38 | 0.090 |
Why?
|
| Ubiquitin-Protein Ligase Complexes | 1 | 2007 | 1 | 0.090 |
Why?
|
| Antigens, Nuclear | 1 | 2007 | 6 | 0.090 |
Why?
|
| F-Box Proteins | 1 | 2007 | 7 | 0.090 |
Why?
|
| Nuclear Matrix-Associated Proteins | 1 | 2007 | 7 | 0.090 |
Why?
|
| Stress, Physiological | 1 | 2007 | 55 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2006 | 39 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2006 | 45 | 0.080 |
Why?
|
| Enzyme Inhibitors | 2 | 2006 | 162 | 0.080 |
Why?
|
| DNA Topoisomerases, Type II | 1 | 2005 | 4 | 0.070 |
Why?
|
| Animals | 4 | 2009 | 7519 | 0.070 |
Why?
|
| Aclarubicin | 1 | 2004 | 1 | 0.070 |
Why?
|
| Thiobarbiturates | 1 | 2004 | 2 | 0.070 |
Why?
|
| Osmosis | 1 | 2004 | 4 | 0.070 |
Why?
|
| Cell Division | 1 | 2005 | 105 | 0.070 |
Why?
|
| Chromosomes | 1 | 2004 | 8 | 0.070 |
Why?
|
| Chromatin | 1 | 2004 | 16 | 0.070 |
Why?
|
| Lasers | 1 | 2004 | 17 | 0.070 |
Why?
|
| Catalysis | 1 | 2004 | 58 | 0.070 |
Why?
|
| Histones | 1 | 2004 | 47 | 0.070 |
Why?
|
| Doxorubicin | 1 | 2004 | 61 | 0.070 |
Why?
|
| Transcription, Genetic | 1 | 2005 | 142 | 0.070 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2004 | 71 | 0.070 |
Why?
|
| Blotting, Western | 1 | 2004 | 280 | 0.070 |
Why?
|
| Cyclin A | 1 | 2002 | 1 | 0.060 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2002 | 9 | 0.060 |
Why?
|
| Cell Culture Techniques | 1 | 2004 | 163 | 0.060 |
Why?
|
| Immunohistochemistry | 1 | 2004 | 498 | 0.060 |
Why?
|
| Time Factors | 2 | 2006 | 2091 | 0.060 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2002 | 40 | 0.060 |
Why?
|
| Cell Line, Tumor | 1 | 2004 | 728 | 0.060 |
Why?
|
| Cell Line | 1 | 2002 | 433 | 0.060 |
Why?
|
| Angiography | 1 | 2019 | 75 | 0.050 |
Why?
|
| Antineoplastic Agents | 1 | 2004 | 598 | 0.050 |
Why?
|
| Reoperation | 1 | 2019 | 165 | 0.050 |
Why?
|
| Embolization, Therapeutic | 1 | 2019 | 83 | 0.050 |
Why?
|
| Nephrectomy | 1 | 2019 | 116 | 0.040 |
Why?
|
| Neoplasm Staging | 1 | 2019 | 468 | 0.040 |
Why?
|
| Organ Size | 1 | 2017 | 220 | 0.040 |
Why?
|
| Biopsy | 1 | 2017 | 251 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2017 | 1098 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2019 | 931 | 0.030 |
Why?
|
| Kidney | 1 | 2017 | 477 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 1246 | 0.030 |
Why?
|
| Adolescent | 1 | 2017 | 3176 | 0.030 |
Why?
|
| Centrosome | 1 | 2009 | 1 | 0.020 |
Why?
|
| Spisula | 1 | 2009 | 1 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2009 | 19 | 0.020 |
Why?
|
| Oocytes | 1 | 2009 | 22 | 0.020 |
Why?
|
| Cattle | 1 | 2009 | 89 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2009 | 58 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2009 | 167 | 0.020 |
Why?
|
| Dyneins | 1 | 2007 | 1 | 0.020 |
Why?
|
| Cyclin B | 1 | 2007 | 1 | 0.020 |
Why?
|
| Chromosomes, Human | 1 | 2007 | 9 | 0.020 |
Why?
|
| CDC2 Protein Kinase | 1 | 2007 | 6 | 0.020 |
Why?
|
| HCT116 Cells | 1 | 2007 | 12 | 0.020 |
Why?
|
| Feedback, Physiological | 1 | 2007 | 9 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2007 | 38 | 0.020 |
Why?
|
| Protein Binding | 1 | 2007 | 198 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2006 | 47 | 0.020 |
Why?
|
| Protein Transport | 1 | 2006 | 79 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2006 | 77 | 0.020 |
Why?
|
| Middle Aged | 1 | 2019 | 11519 | 0.020 |
Why?
|
| Rats | 1 | 2006 | 1739 | 0.010 |
Why?
|
| Female | 1 | 2019 | 18849 | 0.010 |
Why?
|
| Mice | 1 | 2006 | 2367 | 0.010 |
Why?
|